Logo image of ACAD

ACADIA PHARMACEUTICALS INC (ACAD) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ACAD - US0042251084 - Common Stock

25.99 USD
-0.54 (-2.04%)
Last: 1/16/2026, 8:00:00 PM
25.99 USD
0 (0%)
After Hours: 1/16/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ACAD revenue by date.ACAD revenue by date.
-1.239M
-100.26%
-2.445M
-97.38%
-804K
67.12%
1.103B
137,289.05%
1.233B
11.79%
1.366B
10.79%
1.472B
7.76%
1.634B
11.01%
1.826B
11.75%
2.093B
14.62%
2.197B
4.97%
1.6B
-27.17%
EBITDA
YoY % growth
ACAD ebitda by date.ACAD ebitda by date.
297K
100.18%
2.63M
785.52%
14.387M
447.03%
120.89M
740.27%
140.48M
16.20%
237.77M
69.26%
597.24M
151.18%
711.66M
19.16%
1.107B
55.55%
839.66M
-24.15%
1.078B
28.39%
646.88M
-39.99%
EBIT
YoY % growth
ACAD ebit by date.ACAD ebit by date.
-1.733M
98.98%
-2.922M
-68.61%
-1.496M
48.80%
111.31M
7,540.51%
141.79M
27.38%
224.01M
57.99%
338.33M
51.03%
498.91M
47.46%
620.2M
24.31%
734.6M
18.45%
924.42M
25.84%
675.48M
-26.93%
Operating Margin
ACAD operating margin by date.ACAD operating margin by date.
139.90%119.51%186.07%10.09%11.50%16.40%22.98%30.53%33.96%35.10%42.08%42.22%
EPS
YoY % growth
ACAD eps by date.ACAD eps by date.
-0.97
7.62%
-0.38
60.82%
0.48
226.32%
0.82
71.60%
0.81
-2.24%
1.19
47.57%
1.98
66.52%
2.53
27.69%
2.98
18.12%
3.29
10.28%
4.29
30.27%
3.03
-29.22%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.15
846.39%
0.12
13.13%
0.18
14.75%
0.22
-48.51%
0.23
57.16%
Revenue
Q2Q % growth
299.45M
15.35%
288.77M
18.19%
310.82M
17.48%
331.11M
18.83%
351.39M
17.35%
EBITDA
Q2Q % growth
27.249M
19.14%
8.399M
-62.24%
28.147M
-26.43%
36.988M
-17.05%
42.024M
54.22%
EBIT
Q2Q % growth
23.367M
234.39%
29.007M
50.37%
37.749M
16.60%
46.048M
28.78%
56.355M
141.17%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.42
110.00%
0.150.27178.22%
Q2 2025
Q2Q % growth
0.16
-20.00%
0.140.0214.46%
Q1 2025
Q2Q % growth
0.11
10.00%
0.110.00-3.19%
Q4 2024
Q2Q % growth
-0.02
-107.14%
0.22-0.24-109.07%
Q3 2024
Q2Q % growth
0.20
150.00%
0.140.0641.97%
Q2 2024
Q2Q % growth
0.20
1,900.00%
0.180.029.83%
Q1 2024
Q2Q % growth
0.10
137.04%
0.050.05109.49%
Q4 2023
Q2Q % growth
0.28
207.69%
0.31-0.03-9.66%
Q3 2023
Q2Q % growth
-0.40
-135.29%
-0.430.037.97%
Q2 2023
Q2Q % growth
0.01
104.76%
-0.080.09111.87%
Q1 2023
Q2Q % growth
-0.27
18.18%
-0.22-0.05-23.29%
Q4 2022
Q2Q % growth
-0.26
3.70%
-0.25-0.01-4.94%
Q3 2022
Q2Q % growth
-0.17
-88.89%
-0.190.0212.05%
Q2 2022
Q2Q % growth
-0.21
22.22%
-0.250.0416.87%
Q1 2022
Q2Q % growth
-0.33
21.43%
-0.610.2846.18%
Q4 2021
Q2Q % growth
-0.27
35.71%
-0.24-0.03-11.34%
Q3 2021
Q2Q % growth
-0.09
83.33%
-0.270.1866.19%
Q2 2021
Q2Q % growth
-0.27 -0.310.0413.13%
Q1 2021
Q2Q % growth
-0.42
26.32%
-0.540.1222.52%
Q4 2020
Q2Q % growth
-0.42 -0.480.0612.68%
Q3 2020
Q2Q % growth
-0.54 -0.39-0.15-38.11%
Q2 2020
Q2Q % growth
-0.27 -0.450.1840.17%
Q1 2020
Q2Q % growth
-0.57 -0.49-0.08-16.35%
ACAD Yearly EPS VS EstimatesACAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
278.633M
11.27%
282M-3.367M-1.19%
Q2 2025
Q2Q % growth
264.566M
9.34%
267.05M-2.484M-0.93%
Q1 2025
Q2Q % growth
244.317M
18.70%
244.12M197K0.08%
Q4 2024
Q2Q % growth
259.602M
12.36%
283.2M-23.598M-8.33%
Q3 2024
Q2Q % growth
250.401M
18.28%
253.79M-3.389M-1.34%
Q2 2024
Q2Q % growth
241.963M
46.44%
240.37M1.593M0.66%
Q1 2024
Q2Q % growth
205.831M
73.75%
212.46M-6.629M-3.12%
Q4 2023
Q2Q % growth
231.041M
69.26%
228.26M2.781M1.22%
Q3 2023
Q2Q % growth
211.699M
61.97%
193.28M18.419M9.53%
Q2 2023
Q2Q % growth
165.235M
22.76%
160.96M4.275M2.66%
Q1 2023
Q2Q % growth
118.462M
2.56%
122.69M-4.228M-3.45%
Q4 2022
Q2Q % growth
136.5M
4.36%
136.75M-250K-0.18%
Q3 2022
Q2Q % growth
130.7M
-0.68%
141.42M-10.72M-7.58%
Q2 2022
Q2Q % growth
134.6M
16.84%
133.04M1.56M1.17%
Q1 2022
Q2Q % growth
115.5M
8.35%
124.35M-8.85M-7.12%
Q4 2021
Q2Q % growth
130.8M
8.10%
138.1M-7.3M-5.29%
Q3 2021
Q2Q % growth
131.6M
9.12%
130.31M1.29M0.99%
Q2 2021
Q2Q % growth
115.2M
4.63%
127.44M-12.24M-9.60%
Q1 2021
Q2Q % growth
106.6M
18.31%
113.87M-7.27M-6.38%
Q4 2020
Q2Q % growth
121M 125.67M-4.67M-3.72%
Q3 2020
Q2Q % growth
120.6M 121.2M-600K-0.50%
Q2 2020
Q2Q % growth
110.1M 105.41M4.69M4.45%
Q1 2020
Q2Q % growth
90.1M 92.894M-2.794M-3.01%
ACAD Yearly Revenue VS EstimatesACAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS2.09% 8.32% -1.14% 43.73%
Revenue0.07% 2.41% 0% 1.01%